Gene · 3055
Papers2,931
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,931
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Consolidatory ablative stereotactic body radiation therapy after induction chemotherapy for unresectable pancreatic cancer: A single center experience. | Front Oncol | 2022 | 36505838 | PubTator, text mining | PubMed |
| Novel Approaches for the Solid-Phase Synthesis of Dihydroquinazoline-2(1H)-One Derivatives and Biological Evaluation as Potential Anticancer Agents. | Molecules | 2022 | 36500678 | PubTator, text mining | PubMed |
| Natural Products as Anticancer Agents: Current Status and Future Perspectives. | Molecules | 2022 | 36500466 | PubTator, text mining | PubMed |
| Molecular dynamics simulations reveal membrane lipid interactions of the full-length lymphocyte specific kinase (Lck). | Sci Rep | 2022 | 36476673 | PubTator, text mining | PubMed |
| Transcriptome profiling of abdominal aortic tissues reveals alterations in mRNAs of Takayasu arteritis. | Front Genet | 2022 | 36468014 | PubTator, text mining | PubMed |
| HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylation. | Nat Commun | 2022 | 36446791 | PubTator, text mining | PubMed |
| Identification and exploration of novel M2 macrophage-related biomarkers in the development of acute myocardial infarction. | Front Cardiovasc Med | 2022 | 36440001 | PubTator, text mining | PubMed |
| Multi-omics integration reveals a six-malignant cell maker gene signature for predicting prognosis in high-risk neuroblastoma. | Front Neuroinform | 2022 | 36439943 | PubTator, text mining | PubMed |
| Spatiotemporal characteristics of P-selectin-induced β2 integrin activation of human neutrophils under flow. | Front Immunol | 2022 | 36439190 | PubTator, text mining | PubMed |
| Differential Gene Expression of Subcutaneous Adipose Tissue among Lean, Obese, and after RYGB (Different Timepoints): Systematic Review and Analysis. | Nutrients | 2022 | 36432612 | PubTator, text mining | PubMed |
| Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2022 | 36430839 | PubTator, text mining | PubMed |
| Deciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells. | Int J Mol Sci | 2022 | 36430510 | PubTator, text mining | PubMed |
| Integrative and Comprehensive Pan-Cancer Analysis of Lymphocyte-Specific Protein Tyrosine Kinase in Human Tumors. | Int J Mol Sci | 2022 | 36430477 | PubTator, text mining | PubMed |
| Biochemical Targets and Molecular Mechanism of Ginsenoside Compound K in Treating Osteoporosis Based on Network Pharmacology. | Int J Mol Sci | 2022 | 36430397 | PubTator, text mining | PubMed |
| Myeloperoxidase: Regulation of Neutrophil Function and Target for Therapy. | Antioxidants (Basel) | 2022 | 36421487 | PubTator, text mining | PubMed |
| A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma. | Front Genet | 2022 | 36406134 | PubTator, text mining | PubMed |
| Identification of hub genes and transcription factor regulatory network for heart failure using RNA-seq data and robust rank aggregation analysis. | Front Cardiovasc Med | 2022 | 36386304 | PubTator, text mining | PubMed |
| Impact of high-risk of obstructive sleep apnea on chronic cough: data from the Korea National Health and Nutrition Examination Survey. | BMC Pulm Med | 2022 | 36384528 | PubTator, text mining | PubMed |
| IL-33 Induces an Antiviral Signature in Mast Cells but Enhances Their Permissiveness for Human Rhinovirus Infection. | Viruses | 2022 | 36366528 | PubTator, text mining | PubMed |
| Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma. | Cancers (Basel) | 2022 | 36358803 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3055/papers?page=20